LifePulse

Email:

lpbsupport@lifepulsebio.com

Address:

3802 Spectrum Blvd 112C, Tampa, FL 33612

Life Pulse Bioscience

IS CHANGING THE FACE OF ONCOLOGY

40 Years of Research

The First Major Technological Changes in 50 Years

Enhanced Molecular Delivery (EMD) is the use of electrical fields to mediate the delivery of therapeutics at the cellular level.  LifePulse Bioscience, through $33M of research dollars, 40 years of research and dozens of patents, has for the first time, changed the way the modality works. By raising the temperature of the tissue being treated to a specific level and measuring impedance feedback in real time, the potential for over or under treating is eliminated. The traditional technology can cause burns and severe necrosis which has also been eliminated by our patented changes.

Fully Self-contained Medical Device

LifePulse VetPulse C is the first of its kind being engineered and produced in the US

VetPulse C and E provides effective treatment of tumors as a part of adjuvant, neoadjuvant, or palliative care in horses, dogs, cats, exotics and marine life. With its own footprint, the VetPulse is a fully self-contained medical device produced by one of the most recognized names in the US who make devices for many of the medical device brands you would find in your local hospital. We have created our device with the end user in mind, making it simple to use and giving the practitioner assurance of delivery, reduced risk of healthy tissue damage and the peace of mind knowing you are using the most advanced, safe and effective method for treatment available.

More than 100 Patents

What’s the Difference?

Numerous studies have proven both the efficacy and safety of this modality in the treatment of cancerous tumors in equine, feline, and canine subjects in the US and abroad. Dr Richard Heller, and Dr Mark Jaroszeski, the leading scientists for this technology worldwide, have produced more than 100 patents and nearly 100 publications in their quest for the quantum leap forward we have achieved. For years, many vets have been reluctant to incorporate the technology in their practice because of the high voltage, inability to monitor delivery and potential damage to the animal. For the first time, practitioners know in real time that delivery of their chosen therapeutic was successful. Veterinarians familiar with the technology are both relieved and excited about the seismic changes we have made.

Indications

Treating Tumors in Companion Animals

The incidence of cutaneous and subcutaneous cancerous tumors in companion animals has steadily grown over the years, which can lead to shortened lifespans and a reduced quality of life. Treatment of these tumors has traditionally been limited to surgery, chemotherapy, radiation, or a combination of these options. However, due to location or growth patterns, some tumors cannot be treated by these methods and are limited to availability and affordability.

VetPulse C

  • Simple to use device designed with the veterinarian in mind
  • Treats many types of tumors in horses, dogs, and cats
  • Allows for the enhanced delivery of any therapeutic and increased drug absorption
  • Proven efficacy with high success rates and low reoccurrence rates
  • No or minimal systemic side effects
  • New technology virtually eliminates necrosis and risk of healthy tissue damage
  • Can be repeated with equal or improved efficacy
  • Can be used with cytotoxic, non-cytotoxic or no therapeutic

Portable, Affordable, and Effective

VetPulse C
  • Simple to use device designed with the veterinarian in mind
  • Treats many types of tumors in horses, dogs, and cats
  • Allows for the enhanced delivery of any therapeutic and increased drug absorption
  • Proven efficacy with high success rates and low reoccurrence rates
  • No or minimal systemic side effects
  • New technology virtually eliminates necrosis and risk of healthy tissue damage
  • Can be repeated with equal or improved efficacy
  • Can be used with cytotoxic, non-cytotoxic or no therapeutic

LifePulse is the first US engineered and manufactured therapeutic delivery device and the first quantum leap forward in the technology in 50 years. Proven efficacy, the safest and most predictable device ever made, the VetPulse C was designed with advice of Chelsea Tripp, DVM, DACVIM, (O), the leading user of the technology for many years. From ergonomics to functionality and electrode design, the device was engineered with clinical use in mind.